N/A
N=510
Promoting Altruism to Enhance Vaccine Acceptance
Vaccine Refusal
Bottom Line
View on ClinicalTrials.gov: NCT04568590 ↗Enrolled (actual)
510
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Change in Vaccine Hesitancy Scores Pre- and Post-Intervention. — -0.4 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- educational intervention (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Vaccine Hesitancy Scores Pre- and Post-Intervention. |
-0.4 | — |
| PRIMARY Pre-Intervention Vaccine Hesitancy Score |
3.81 | — |
| PRIMARY Post-Intervention Vaccine Hesitancy Score |
3.42 | — |
| SECONDARY Rate of Influenza Vaccine Uptake |
8 | — |
| SECONDARY Pre-Intervention Altruism Scale |
60.4 | — |
Summary
Subjects enrolled in this study are eligible for the seasonal influenza vaccine. The purpose of this research study is to figure out if increasing individuals' awareness of the benefits of herd immunity, specifically to the local pediatric oncology community, can improve vaccination uptake rates.
Eligibility Criteria
Inclusion Criteria
- All legal guardians of children aged 6 months and up who are influenza vaccine-eligible and present to the pediatric clinic.
Exclusion Criteria
- Legal guardians of children who are not influenza vaccine-eligible including children less than 6 months of age, children on immunosuppressive medications, and children with underlying medical conditions resulting in an immunocompromised state.
Data sourced from ClinicalTrials.gov (NCT04568590). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.